Is Indian Pharma Market on the Track to reach $130 Billion by 2030? The #Indianpharmaceutical_industry has experienced transformative growth and #challenges in 2024, making it a pivotal year for innovation, sustainability, and global competitiveness. With advancements in drug discovery, regulatory shifts, and the integration of #digital_technologies, Indian pharma continues to shape global healthcare trends while addressing domestic needs through government initiatives like #AyushmanBharat and the Production-Linked Incentive (#PLI) scheme. ETPharma brings together eminent leaders in the Indian pharmaceutical industry to discuss the major achievements and outlook for year 2025 Live Webinar on: December 4th, 2024, 12:00 pm onwards Speakers: Sudarshan Jain I Dr SV Veeramani I Sheetal Sapale I Vikas Dandekar I Rashmi Mabiyan Kaur #PharmaIndustry I #Growth_Prospects I #Domesticmarket I #Exports I #Estimates I #Generics I #Biosimilars I #Innovative_Drugs Register to join the webinar: https://lnkd.in/ggppfAqi
Thanks for sharing
Pharmaceutical Quality Professionals (Former Quality Lead in Pfizer, Mylan, USP, Cipla, Dr.Reddy's and Perrigo)
7hPl resend the link